Open Up a World
WHERE MORE THAN ONE PATIENT
TYPE CAN BE TREATED
Explore how DUPIXENT may help different types of patients achieve symptom control.
Signs and symptoms of
- Shortness of breath
- Nighttime awakening due
- Frequent exacerbations
- Impaired lung function
- Frequent albuterol use
- Activity limitation due to asthma
DUPIXENT is indicated as an add-on maintenance treatment of adult and pediatric patients aged 6 years and older with moderate-to-severe asthma characterized by an eosinophilic phenotype or with oral corticosteroid dependent asthma. Limitation of Use: DUPIXENT is not indicated for the relief of acute bronchospasm or status asthmaticus.1
Help appropriate patients benefit from the only dual inhibitor indicated in moderate-to-severe asthma1
Patient profiles are representative and are not actual DUPIXENT patients. Examples of patients with moderate-to-severe asthma with an eosinophilic phenotype or with OCS-dependent asthma.
OCS, oral corticosteroid.